Pharmaceutical Business review

ECR Pharma rolls out Zolpimist Oral Spray in US

The Zolpimist Oral Spray unit contains 60 metered sprays and provides the flexibility of administering either a 5 or 10 mg dose of the zolpidem active ingredient, ECR Pharmaceuticals said.

As with most prescription hypnotic agents, Zolpimist Oral Spray is federally classified as a CIV controlled substance and is only available by prescription.

Hi-Tech president and CEO David Seltzer said Zolpimist is a significant addition to ECR and reflects their continuing commitment to build this segment of their business through the marketing of widely used, innovative products.